Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Indy Hematology Review

A. Tefferi

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Experts Discuss Pros and Cons of Treatment Approaches in PV

BMFcases

T. Bat, A. Tefferi

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

2024 Updates in PV/ET

University of Colorado Division of Hematology

B. McMahon

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

Diagnosis and Prognosis in PV: Utility of BM Biopsy, Clinical Findin…

BMFcases

T. Bat, A. Tefferi

Switching ITP Patients to Avatrombopag From Other TPO-RAs: When to D…

Keck School of Medicine of USC

H. Liebman

What to Do When Patch Testing is Negative?

American Contact Dermatitis Society (ACDS)

M. Montanez-Wiscovich

2024 Benign Hematology Updates

University of Colorado Division of Hematology

L. Chu

Management of iTTP

Yazan Abou-Ismail

Evolving Treatment Landscape in ITP

Robert Bird

Clots in the Visceral and Cerebral Veins: Evidence, Guidelines and T…

Marc Zumberg